Detail
| LncRNA Name | LINC00663 |
| Synonyms | MGC39821 |
| Region | GRCh38_19:19757366-19776423 Sequence |
| Ensembl | ENSG00000266904 |
| RefSeq | NR_026956 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✔ |
| Variant | ✔ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR etc. |
| Sample | cell lines (DU-145 and PC3) |
| Expression Pattern | down-regulated |
| Function Description | Additionally, LINC00663 was shown to be expressed at low levels in DU-145 and PC3 prostate cancer, HGC-27 stomach carcinoma, CRL-1469 pancreatic carcinoma, A549 lung cancer, MCF7 breast cancer, and BCPAP thyroid cancer cell lines |
| Pubmed ID | 26743782 |
| Year | 2016 |
| Title | A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples. |
| External Links |
| Links for LINC00663 | GenBank HGNC lncrnadb Noncode |
| Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.